Semaglutide vs Tirzepatide vs Retatrutide: Which GLP-1 Is Best for Weight Loss?
If you’re researching medical weight loss, three names dominate the conversation: Semaglutide, Tirzepatide and the newer Retatrutide. All three are GLP-1-based compounds, all are injected weekly, and all can drive significant fat loss — but they are not the same. This guide breaks down how they differ and how to choose the right one for your goal and experience level.
The quick answer
- Semaglutide — the proven, well-tolerated starting point. Best for first-time users.
- Tirzepatide — a dual-action molecule with greater average weight loss in clinical trials. Best for maximum results.
- Retatrutide — the next-generation triple agonist showing the strongest early data. Best for experienced users chasing the cutting edge.
How each one works
Semaglutide (GLP-1)
Semaglutide is a single GLP-1 receptor agonist. It slows gastric emptying, blunts appetite and reduces “food noise,” making it easier to eat less without a constant battle against hunger. It is the most studied of the three and has the longest track record, which is why it’s the usual recommendation for beginners.
Tirzepatide (GIP + GLP-1)
Tirzepatide adds a second pathway: it activates both GIP and GLP-1 receptors. This dual action tends to produce greater average weight loss than semaglutide alone in head-to-head clinical data, while keeping the same convenient once-weekly dosing. It has quickly become the most popular option for people who want stronger results.
Retatrutide (GIP + GLP-1 + Glucagon)
Retatrutide is a triple agonist — it adds a glucagon pathway on top of GIP and GLP-1. Early trials have reported some of the largest weight-reduction figures seen to date. As the newest compound, it’s best suited to experienced users who already understand how their body responds to GLP-1 therapy.
Side-by-side comparison
| Sémaglutide | Tirzépatide | Rétatrutide | |
|---|---|---|---|
| Mechanism | GLP-1 | GIP + GLP-1 | Triple |
| Dosing | Weekly | Weekly | Weekly |
| Relative potency | ●● | ●●● | ●●●● |
| Best for | Beginners | Max results | Experienced |
Which should you choose?
If this is your first GLP-1 protocol, Semaglutide is the sensible entry point — gentle, predictable and affordable. If you’ve used GLP-1 before or want the strongest widely-available option, Tirzepatide is the go-to. And if you’re an experienced user who wants the newest science, Retatrutide is worth exploring.
Compare Semaglutide, Tirzepatide and Retatrutide — lab-tested, discreet EU delivery.
Frequently asked questions
Is Tirzepatide better than Semaglutide? In clinical trials Tirzepatide produced greater average weight loss, thanks to its dual GIP + GLP-1 action. It is stronger, but Semaglutide remains an excellent, gentler starting point.
Can I switch between them? Many users start on Semaglutide and move to Tirzepatide or Retatrutide as they progress. Always re-titrate from a low dose when switching.
For research and laboratory use. This article is general information, not medical advice. GLP-1 compounds may be prescription-only or controlled in your jurisdiction — verify local regulations. Consult a qualified healthcare professional before starting any protocol.